SPINDLE CELL RHABDOMYOSARCOMA
Clinical trials for SPINDLE CELL RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new SPINDLE CELL RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for SPINDLE CELL RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise against aggressive childhood cancer
Disease control OngoingThis study tests whether adding a drug called vinorelbine to standard chemotherapy can better control high-risk rhabdomyosarcoma, a rare and aggressive muscle cancer in children and young adults. About 118 participants will receive either the standard treatment or the new combina…
Matched conditions: SPINDLE CELL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 17, 2026 00:27 UTC
-
Can adding temsirolimus boost chemo for kids and young adults with muscle cancer?
Disease control OngoingThis study tests whether adding the drug temsirolimus to standard chemotherapy helps people with intermediate-risk rhabdomyosarcoma (a type of muscle cancer) live longer without the cancer growing or coming back. About 325 participants up to age 40 are randomly assigned to receiv…
Matched conditions: SPINDLE CELL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC